Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...
CVS is fighting to protect its PBM business as Trump and Congress look for ways to take out the pharmacy "middlemen." ...
Korlym is Corcept's only approved drug, though the company (Nasdaq: CORT) asked the FDA in December to greenlight ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...
Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.
The theory behind leucovorin's use for autism postulates that some children have a blockage in the transport of folic acid into the brain that potentially contributes to neurological symptoms.
India's Contract Research, Development, and Manufacturing Organization (CRDMO) industry is on a strong growth trajectory, ...
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
The cuts included about 20 people in the FDA’s office of neurological and physical medicine devices, several of whom worked ...